Search Results - "Cobham, M."

Refine Results
  1. 1
  2. 2

    Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary by Chuang, E., Wiener, N., Christos, P., Kessler, R., Cobham, M., Donovan, D., Goldberg, G.L., Caputo, T., Doyle, A., Vahdat, L., Sparano, J.A.

    Published in Annals of oncology (01-10-2010)
    “…Background: Ixabepilone is a semisynthetic epothilone B analogue that is active in taxane-resistant cell lines and has shown activity in patients with…”
    Get full text
    Journal Article
  3. 3

    Sexual transmission of human T-lymphotropic virus type I (HTLV-I) by Murphy, E L, Figueroa, J P, Gibbs, W N, Brathwaite, A, Holding-Cobham, M, Waters, D, Cranston, B, Hanchard, B, Blattner, W A

    Published in Annals of internal medicine (01-10-1989)
    “…To study the seroprevalence of human T-lymphotropic virus type I (HTLV-I) in a sexually active population and to determine sexual behavior risk factors for…”
    Get more information
    Journal Article
  4. 4

    Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants by Murphy, E L, Figueroa, J P, Gibbs, W N, Holding-Cobham, M, Cranston, B, Malley, K, Bodner, A J, Alexander, S S, Blattner, W A

    Published in American journal of epidemiology (01-06-1991)
    “…During 1985 and 1986, the authors measured antibodies to human T-lymphotropic virus type I (HTLV-I) in a cohort of 13,260 Jamaicans from all parts of the…”
    Get more information
    Journal Article
  5. 5

    Abstract P1-10-10: Tumor infiltrating lymphocytes (TILS) among high risk for recurrence breast cancer patients treated with tetrathimolybdate (TM) by Rybstein, MD, Nackos, E, Kornhauser, N, Cigler, T, Andreopoulou, E, Moore, A, Cobham, M, Fitzpatrick, V, Demaria, S, Vahdat, LT

    Published in Cancer research (Chicago, Ill.) (15-02-2018)
    “…Background: Tumor infiltrating lymphocytes (TILs) evaluated in the primary tumor biopsy or surgical resection have been well established as having prognostic…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. II. Geographic and ecologic determinants by Maloney, E M, Murphy, E L, Figueroa, J P, Gibbs, W N, Cranston, B, Hanchard, B, Holding-Cobham, M, Malley, K, Blattner, W A

    Published in American journal of epidemiology (01-06-1991)
    “…An island-wide cohort of 13,260 Jamaicans who applied for food-handling licenses during 1985 and 1986 were tested for antibodies to human T-cell lymphotropic…”
    Get more information
    Journal Article
  10. 10

    Abstract P2-16-14: The Effect of Tetrathiomolybdate (TM) on Circulating Endothelial Progenitor Cells in Women at Moderate to High Risk of BC Recurrence by Jain, S, Ward, MM, O'Laughlin, J, Chuang, E, Cigler, T, Moore, A, Donovan, D, Schneider, S, Cobham, M, Wiener, N, Lam, C, Christos, PJ, Lane, ME, Rafii, S, Vahdat, LT

    Published in Cancer research (Chicago, Ill.) (15-12-2010)
    “…Background: Bone marrow (BM) derived endothelial progenitor cells (EPCs) are critical to tumor angiogenesis, are increased in BC patients (pts) and are…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Phase I trial of a histone deacetylase inhibitor (HDACI) and retinoid acid (RA) in patients (pts) with advanced solid tumor malignancies by Atieh, D. M., Milowsky, M. I., Cobham, M., Kaplan, J., Smith, C., Gudas, L. J., Nanus, D. M.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 13114 Background: Transcription of RA responsive genes is inhibited by co-repressor complexes which have HDAC activity. Pre-clinical data…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Phase 1/2 Clinical Trial of Interferon [alpha]2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma by Boorjian, SA, Milowsky, MI, Kaplan, J, Albert, M, Cobham, M V, Coll, D M, Mongan, N P, Shelton, G, Petrylak, D, Gudas, L J, Nanus, D M

    Published in Journal of immunotherapy (1997) (01-09-2007)
    “…To evaluate the feasibility, efficacy, and biologic effects of weekly liposome-encapsulated all-trans retinoic acid (ATRA-IV) plus interferon [alpha]2b (IFN)…”
    Get full text
    Journal Article
  17. 17

    Abstract P6-05-06: Association of HER2/neu single nucleotide polymorphism with trastuzumab-related cardiotoxicity by Chuang, E, Stanton, S, Ward, MM, Christos, P, Sanford, R, Lam, C, Cobham, MV, Donovan, D, Scheff, R, Cigler, T, Moore, A, Vahdat, LT, Lane, ME

    Published in Cancer research (Chicago, Ill.) (15-12-2013)
    “…Background: Treatment with trastuzumab prolongs overall survival when given to patients (pts) with Her2/neu+ breast cancer (BC). The primary toxicity of…”
    Get full text
    Journal Article
  18. 18

    Abstract P6-11-04: Targeting the tumor microenvironment: tetrathiomolybdate decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse by Jain, S, Kornhauser, N, Lam, C, Ward, MM, Chuang, E, Cigler, T, Moore, A, Donovan, D, Cobham, MV, Schneider, S, Hurtado, Rua SM, Lane, ME, Mittal, V, Vahdat, LT

    Published in Cancer research (Chicago, Ill.) (15-12-2012)
    “…Background: Bone marrow-derived endothelial progenitor cells (EPCs) constitute an important part of the tumor microenvironment and are critical for metastatic…”
    Get full text
    Journal Article
  19. 19

    Abstract P1-15-07: Ixabepilone-associated peripheral neuropathy in metastatic breast cancer patients and its effects on the ultrastructure of neurons by Jain, S, Carlson, K, Chuang, E, Cigler, T, Moore, A, Donovan, D, Lam, C, Cobham, MV, Schneider, S, Ramnarain, A, Carey, B, Ward, M, Lane, M, Strickland, S, Vahdat, L

    Published in Cancer research (Chicago, Ill.) (15-12-2012)
    “…Background: Peripheral neuropathy is a dose-limiting toxicity of most microtubule-stabilizing chemotherapeutic agents. Ixabepilone, a semisynthetic analog of…”
    Get full text
    Journal Article
  20. 20

    The effect of tetrathiomolybdate on circulating endothelial progenitor cells in patients with breast cancer at high risk of recurrence by Blinder, VS, Lane, ME, Ward, MM, Chuang, E, Cigler, T, Moore, AL, Scheff, RJ, Cobham, ME, Donovan, D, Rice, D, Christos, PJ, Vahdat, LT

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…Abstract #1036 Background: Endothelial progenitor cells are critical to tumor angiogenesis and are increased in breast cancer patients. Copper is required for…”
    Get full text
    Journal Article